Boston Scientific to buy Endo's urology portfolio for $1.65 billion

March 2, 2015 1:17 PM

12 0

(Reuters) - Medical device maker Boston Scientific Corp (BSX.N) said it will buy Endo International Plc's (ENDP.O) American Medical Systems' men's and prostate health business for up to $1.65 billion.

The purchase ends a nearly decade-long deal drought for Boston Scientific, which has not completed a large takeover since its 2006 acquisition of heart device maker Guidant Corp for $27 billion.

Also read: Wyndham Worldwide buying La Quinta for $1.95 billion

Read more

To category page